Sagent Company Profile
What is the competitive landscape for SAGENT
SAGENT has ninety-two approved drugs.
There is one tentative approval on SAGENT drugs.
Summary for Sagent
| US Patents: | 0 |
| Tradenames: | 72 |
| Ingredients: | 69 |
| NDAs: | 92 |
| Patent Litigation for Sagent: | See patent lawsuits for Sagent |
Drugs and US Patents for Sagent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090581-001 | Oct 20, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 201835-002 | Jun 27, 2018 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms | HALOPERIDOL | haloperidol lactate | INJECTABLE;INJECTION | 200742-001 | Sep 2, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
